Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection

Aim. To determine the prognostic significance of N-terminal pro-brain natriuretic peptide (NT-proBNP) and soluble ST2 (sST2) in patients with post-myocardial infarction heart failure after a coronavirus disease 2019 (COVID-19)Material and methods. Three following groups were formed: in patients of g...

Full description

Saved in:
Bibliographic Details
Main Authors: N. M. Kalashnikova, D. N. Zaitsev, A. V. Govorin, M. V. Chistyakova, B. T. Balzhitov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2023-07-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5216
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250058986323968
author N. M. Kalashnikova
D. N. Zaitsev
A. V. Govorin
M. V. Chistyakova
B. T. Balzhitov
author_facet N. M. Kalashnikova
D. N. Zaitsev
A. V. Govorin
M. V. Chistyakova
B. T. Balzhitov
author_sort N. M. Kalashnikova
collection DOAJ
description Aim. To determine the prognostic significance of N-terminal pro-brain natriuretic peptide (NT-proBNP) and soluble ST2 (sST2) in patients with post-myocardial infarction heart failure after a coronavirus disease 2019 (COVID-19)Material and methods. Three following groups were formed: in patients of group I (main), who underwent inpatient treatment for COVID-19, the cause of heart failure (HF) was prior Q-wave myocardial infarction; in patients of group II (comparison) without COVID-19, the cause of HF was prior Q-wave myocardial infarction; Group III (comparison) — patients with HF of ischemic origin without postinfarction cardiosclerosis and COVID-19. Statistical processing was carried out using the software package IBM SPSS Statistics Version 26.0.Results. The patients of all three groups included in the present study were comparable. After 6 months in group I, HF course worsening was recorded. In patients of groups I and II, an increase in NYHA HF class from 2 to 3 and 4 was recorded, in contrast to patients of group III, among whom the number of patients with class 3 HF decreased by 25% due to compensation to class 2. Patients of the studied groups, who had elevated serum levels of NT-proBNP and sST2, had more pronounced structural and functional myocardial disorders than patients with normal levels of these biomarkers. Using analysis of adverse cardiovascular events, such as recurrent myocardial infarction, cerebrovascular accident, hospitalization due to coronary artery disease, decompensated HF, which required hospitalization, a predictive model was developed using a neural network. There were following most important factors of the developed model: age, level of NT-proBNP and sST2, lung involvement according to computed tomography.Conclusion. Modern biomarkers NT-proBNP and sST2 have sufficient predictive value to determine the risk of adverse events in HF.
format Article
id doaj-art-13e19872ece5499c96f80537e0dbf8d0
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2023-07-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-13e19872ece5499c96f80537e0dbf8d02025-08-20T03:57:22Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-07-0128610.15829/1560-4071-2023-52163810Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infectionN. M. Kalashnikova0D. N. Zaitsev1A. V. Govorin2M. V. Chistyakova3B. T. Balzhitov4Chita State Medical AcademyChita State Medical AcademyChita State Medical AcademyChita State Medical AcademyCity Clinical Hospital № 1Aim. To determine the prognostic significance of N-terminal pro-brain natriuretic peptide (NT-proBNP) and soluble ST2 (sST2) in patients with post-myocardial infarction heart failure after a coronavirus disease 2019 (COVID-19)Material and methods. Three following groups were formed: in patients of group I (main), who underwent inpatient treatment for COVID-19, the cause of heart failure (HF) was prior Q-wave myocardial infarction; in patients of group II (comparison) without COVID-19, the cause of HF was prior Q-wave myocardial infarction; Group III (comparison) — patients with HF of ischemic origin without postinfarction cardiosclerosis and COVID-19. Statistical processing was carried out using the software package IBM SPSS Statistics Version 26.0.Results. The patients of all three groups included in the present study were comparable. After 6 months in group I, HF course worsening was recorded. In patients of groups I and II, an increase in NYHA HF class from 2 to 3 and 4 was recorded, in contrast to patients of group III, among whom the number of patients with class 3 HF decreased by 25% due to compensation to class 2. Patients of the studied groups, who had elevated serum levels of NT-proBNP and sST2, had more pronounced structural and functional myocardial disorders than patients with normal levels of these biomarkers. Using analysis of adverse cardiovascular events, such as recurrent myocardial infarction, cerebrovascular accident, hospitalization due to coronary artery disease, decompensated HF, which required hospitalization, a predictive model was developed using a neural network. There were following most important factors of the developed model: age, level of NT-proBNP and sST2, lung involvement according to computed tomography.Conclusion. Modern biomarkers NT-proBNP and sST2 have sufficient predictive value to determine the risk of adverse events in HF.https://russjcardiol.elpub.ru/jour/article/view/5216post-myocardial infarction heart failurecoronavirus infection­nt-probnpsst2
spellingShingle N. M. Kalashnikova
D. N. Zaitsev
A. V. Govorin
M. V. Chistyakova
B. T. Balzhitov
Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
Российский кардиологический журнал
post-myocardial infarction heart failure
coronavirus infection
­nt-probnp
sst2
title Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
title_full Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
title_fullStr Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
title_full_unstemmed Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
title_short Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
title_sort prognostic significance of nt probnp and sst2 biomarkers in patients with post myocardial infarction heart failure after a coronavirus infection
topic post-myocardial infarction heart failure
coronavirus infection
­nt-probnp
sst2
url https://russjcardiol.elpub.ru/jour/article/view/5216
work_keys_str_mv AT nmkalashnikova prognosticsignificanceofntprobnpandsst2biomarkersinpatientswithpostmyocardialinfarctionheartfailureafteracoronavirusinfection
AT dnzaitsev prognosticsignificanceofntprobnpandsst2biomarkersinpatientswithpostmyocardialinfarctionheartfailureafteracoronavirusinfection
AT avgovorin prognosticsignificanceofntprobnpandsst2biomarkersinpatientswithpostmyocardialinfarctionheartfailureafteracoronavirusinfection
AT mvchistyakova prognosticsignificanceofntprobnpandsst2biomarkersinpatientswithpostmyocardialinfarctionheartfailureafteracoronavirusinfection
AT btbalzhitov prognosticsignificanceofntprobnpandsst2biomarkersinpatientswithpostmyocardialinfarctionheartfailureafteracoronavirusinfection